Radical hysterectomy case volume and cervical cancer treatment in the era of COVID-19: A multi-site analysis of National Cancer Institute-designated Comprehensive Cancer Centers.

Autor: Wickenheisser NE; Department of Obstetrics & Gynecology, Duke University Health System, Durham, NC, United States of America., Dillon M; Biostatistics Shared Resources, Duke Cancer Institute, Durham, NC, United States of America., Broadwater G; Biostatistics Shared Resources, Duke Cancer Institute, Durham, NC, United States of America., Zacherl K; Department of Obstetrics & Gynecology, Duke University Health System, Durham, NC, United States of America., Bixel K; Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Ohio State University Wexner Medical Center, Columbus, OH, United States of America., Levine M; Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Ohio State University Wexner Medical Center, Columbus, OH, United States of America., Newton M; Divison of Gynecologic Oncology, Department of Obstetrics & Gynecology, University of North Carolina Medical Center, Chapel Hill, NC, United States of America., Thel H; University of North Carolina School of Medicine, Chapel Hill, NC, United States of America., Tucker K; Divison of Gynecologic Oncology, Department of Obstetrics & Gynecology, University of North Carolina Medical Center, Chapel Hill, NC, United States of America., Gehrig P; Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, University of Virginia School of Medicine, Charlottesville, VA, United States of America., Khetan VU; Divison of Gynecologic Oncology, Department of Obstetrics & Gynecology, Keck School of Medicine of University of Southern California, Los Angeles, CA, United States of America., Brunette-Masi LL; Divison of Gynecologic Oncology, Department of Obstetrics & Gynecology, Keck School of Medicine of University of Southern California, Los Angeles, CA, United States of America., Matsuo K; Divison of Gynecologic Oncology, Department of Obstetrics & Gynecology, Keck School of Medicine of University of Southern California, Los Angeles, CA, United States of America., Khouri OR; Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Montefiore Medical Center, Bronx, NY, United States of America., Duhon A; Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Montefiore Medical Center, Bronx, NY, United States of America., Gowthaman D; Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Montefiore Medical Center, Bronx, NY, United States of America., Cowan M; Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Montefiore Medical Center, Bronx, NY, United States of America., Mojdehbakhsh R; Divison of Gynecologic Oncology, Department of Obstetrics & Gynecology, University of Wisconsin Health, Madison, WI, United States of America., Rose S; Divison of Gynecologic Oncology, Department of Obstetrics & Gynecology, University of Wisconsin Health, Madison, WI, United States of America., Olawaiye A; Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, University of Pittsburgh Medical Center, Pittsburgh, PA, United States of America., Davidson BA; Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Duke University Health System, Durham, NC, United States of America., Moss HA; Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Duke University Health System, Durham, NC, United States of America., Havrilesky LJ; Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Duke University Health System, Durham, NC, United States of America. Electronic address: havri001@mc.duke.edu.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2023 Dec; Vol. 179, pp. 70-78. Date of Electronic Publication: 2023 Nov 07.

Understanding the needs and perspectives of ovarian cancer patients when considering PARP inhibitor maintenance therapy: Findings from two online community events.

Autor: Monuszko KA; Duke University School of Medicine, Durham, NC 27710, USA., Fish LJ; Department of Family Medicine and Community Health, Duke University School of Medicine, Durham, NC 27710, USA.; Duke Cancer Institute, Durham, NC 27710, USA., Sparacio D; #gyncsm (Gynecologic Cancer Social Media) Community, USA., Lizaso C; #gyncsm (Gynecologic Cancer Social Media) Community, USA., Burn K; Smart Patients Online Community, USA., Wickenheisser NE; Duke University School of Medicine, Durham, NC 27710, USA., Meyer LA; Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Reed SD; Duke Clinical Research Institute, Durham, NC 27710, USA.; Department of Population Health Sciences, Duke University, Durham, NC 27710, USA., Davidson BA; Division of Gynecologic Oncology, Duke Cancer Institute, Durham, NC 27710, USA., Havrilesky LJ; Division of Gynecologic Oncology, Duke Cancer Institute, Durham, NC 27710, USA.

Publikováno v: Gynecologic oncology reports [Gynecol Oncol Rep] 2022 Jul 26; Vol. 43, pp. 101050. Date of Electronic Publication: 2022 Jul 26 (Print Publication: 2022).